Franklin Resources’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.3M Buy
3,278,549
+735,452
+29% +$7.05M 0.01% 882
2025
Q4
$29.6M Buy
2,543,097
+145,085
+6% +$1.41M 0.01% 830
2025
Q3
$24.1M Buy
2,398,012
+569,257
+31% +$8.17M 0.01% 891
2025
Q2
$31.9M Sell
1,828,755
-28,789
-2% -$415K 0.01% 772
2025
Q1
$23.4M Sell
1,857,544
-118,868
-6% -$1.43M 0.01% 855
2024
Q4
$20.9M Sell
1,976,412
-860,840
-30% -$12.1M 0.01% 902
2024
Q3
$42.4M Sell
2,837,252
-113,711
-4% -$1.35M 0.01% 660
2024
Q2
$25.1M Hold
2,950,963
0.01% 780
2024
Q1
$30.2M Sell
2,950,963
-1,147,534
-28% -$8.56M 0.01% 737
2023
Q4
$22.5M Buy
4,098,497
+229,988
+6% +$1.01M 0.01% 728
2023
Q3
$14.6M Buy
+3,868,509
New +$25.4M 0.01% 824
2021
Q3
Sell
-224,208
Closed -$6.93M 2496
2021
Q2
$6.93M Buy
224,208
+24,200
+12% +$776K ﹤0.01% 1076
2021
Q1
$8.73M Hold
200,008
﹤0.01% 1002
2020
Q4
$9.27M Buy
+200,008
New +$6.68M ﹤0.01% 977

Other funds holding SPRY